FDA Inspection 1076077 — CMIC Pharma Science Co., Ltd.

CMIC Pharma Science Co., Ltd. — FEI 3011029035

The FDA completed an inspection of CMIC Pharma Science Co., Ltd. on Dec 5, 2018 in Ishikari. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 5, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ishikari (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.